22.11.2026 22:57:01

SI-BONE: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Nov. 2, 2026, SI-BONE (NASDAQ:SIBN) announced a 15% increase in worldwide revenue to $55.7 million, driven by expanding adoption of its surgical implants. The medical device maker is extending its anatomical fixation products into wider spinal applications, positioning itself to capture a larger share of complex surgeries.

Three things management said stand out.

Management launched iFuse Granite Onyx, a medical device designed to fix spinal fusion failures, following clearance from the Food and Drug Administration (FDA). This product extends the company's addressable market by targeting procedures that suffer from high failure rates.

Continue reading

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

SI-BONE Inc Registered Shs 21,60 0,00% SI-BONE Inc Registered Shs